Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > Premium Reta RT15 Research Peptides | Advanced Weight Management & Fitness Bodybuilding Peptides
Premium Reta RT15 Research Peptides | Advanced Weight Management & Fitness Bodybuilding Peptides buy - large image1
Premium Reta RT15 Research Peptides | Advanced Weight Management & Fitness Bodybuilding Peptides buy - image1
Premium Reta RT15 Research Peptides | Advanced Weight Management & Fitness Bodybuilding Peptides buy - image2
Premium Reta RT15 Research Peptides | Advanced Weight Management & Fitness Bodybuilding Peptides buy - image3
Premium Reta RT15 Research Peptides | Advanced Weight Management & Fitness Bodybuilding Peptides buy - image4
Premium Reta RT15 Research Peptides | Advanced Weight Management & Fitness Bodybuilding Peptides buy - image5
Premium Reta RT15 Research Peptides | Advanced Weight Management & Fitness Bodybuilding Peptides buy - image6

Premium Reta RT15 Research Peptides | Advanced Weight Management & Fitness Bodybuilding Peptides

7449 Inquiries

Unit Price:

$85/G FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

98%

Port:

深圳

Brand:

hongzongyue

Packaging:

5mg\10mg\15mg\20mg\30mg\40mg\50mg\60mg/vial; 10vials

Price valid (until):

2029-07-30

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
11 days
Qualification:
Main Products:

Peptide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    Overview Discover premium-grade Retatrutide (LY3437943) lyophilized powder, meticulously synthesized under strict laboratory protocols to ensure exceptional stability and chemical integrity for your research projects. As a trusted global peptide manufacturer, we deliver consistent, batch-to-batch excellence to support independent laboratories, clinical researchers, and specialized distributors worldwide.

    Product Specifications:

    • Product Name: Retatrutide (Reta / RT)

    • CAS Number: 2381089-83-2

    • Appearance: Pure white lyophilized cake / powder

    • Purity: ≥99% (Verified by HPLC & MS analysis)

    • Format: Vacuum-sealed glass vials

    • Available Specifications: 5mg / 10mg / 15mg / 30mg per vial (Custom sizing available upon request)

    Why Choose Our Research Peptides?

    • Verified Ultra-High Purity: Every batch is backed by a verifiable Certificate of Analysis (CoA), guaranteeing maximum purity and minimal impurities for reliable experimental results.

    • Advanced Lyophilization Technology: Our specialized freeze-drying and vacuum-sealing processes protect the peptide structure from degradation, ensuring optimal shelf-life and thermal stability during transit.

    • Professional Customization: We offer advanced purification options, including TFA (Trifluoroacetic acid) removal, to fulfill the rigorous standards of high-end research facilities.

    • Secure & Discreet Packaging: Standardized laboratory packaging ensures product safety and hassle-free international logistics.

    Storage & Stability Guidelines

    To maintain the long-term integrity of the lyophilized peptide, please follow standard laboratory storage protocols:

    • Short-Term Storage (During Shipping/Handling): Stable at room temperature ($20^\circ\text{C}$ to $25^\circ\text{C}$) for up to several weeks.

    • Long-Term Storage: Store in a dry, dark environment at $-20^\circ\text{C}$ or below to prevent structural degradation.

    • Handling Note: Allow the vial to adjust to room temperature before opening to avoid moisture condensation inside the vial.

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Polypeptide

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptide

    Location:

    Room 1501, Building 1, Changnan Mansion, Country Garden, on the west side of Taoyang North Road

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    11 days

    Year of Establishment:

    2025

  • Inquiry History
    7449 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Palestine

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    10 MG Mar 16, 2026
    United States

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    20 MG Feb 4, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.